Gossamer Bio
GOSS
95 hedge funds and large institutions have $171M invested in Gossamer Bio in 2023 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 34 closing their positions.
397% more call options, than puts
Call options by funds: $2.67M | Put options by funds: $538K
130% more capital invested
Capital invested by funds: $74.4M → $171M (+$96.8M)
63% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 19
26.25% more ownership
Funds ownership: 64.97% → 91.23% (+26%)
9% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 34
4% less funds holding
Funds holding: 99 → 95 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$14.1M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$10.6M |
| 3 |
AVM
Arch Venture Management
Chicago,
Illinois
|
+$9.28M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.86M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.77M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.58M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$1.49M |
| 4 |
Two Sigma Investments
New York
|
-$1.19M |
| 5 |
Two Sigma Advisers
New York
|
-$748K |
GOSS Hedge Fund Activity: Q3 2023 in Review
95 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2023, worth a combined $171M — up 130% from $74.4M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of GOSS and 31 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 31 added.
The largest buyer was NEA Management Company, adding an estimated $14.1M. The largest seller was Acadian Asset Management, cutting an estimated $1.77M.
- 95 institutional investors held Gossamer Bio (GOSS) as of Q3 2023, down from 99 in Q2 2023.
- Funds reported $171M of Gossamer Bio stock for Q3 2023, up 130% quarter-over-quarter.
- 31 funds opened new Gossamer Bio positions in Q3 2023 and 34 closed out, a net change of -3 holders.
- The largest Gossamer Bio buyer in Q3 2023 was NEA Management Company, an estimated $14.1M added.
- The largest Gossamer Bio seller in Q3 2023 was Acadian Asset Management, an estimated $1.77M sold.
Based on aggregated 13F filings for Q3 2023.